Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales there of its biosimilar ...
Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from ...
Seattle-based Sana Biotechnology Inc. (Nasdaq: SANA) is losing its research and development lead. In a Thursday filing with ...
Due to slow uptake of its Humira biosimilar Cyltezo in the U.S., Boehringer Ingelheim is laying off an undisclosed number of ...
Even with discounts that reach as high as 86%, Humira biosimilars are finding it difficult to take market share away from the ...
In this article, we will take a detailed look at Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024. For a quick ...
Wall Street stocks were in the green early on Monday as retail sales boosted sentiment and market participants prepared for ...
US stocks were mostly lower on Thursday with the S&P 500 and Nasdaq falling for the fifth straight day as another rise in ...